These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 23887608

  • 21. A nomogram for predicting immunoglobulin-resistant Kawasaki disease in children.
    Pan Y, Fan Q.
    J Int Med Res; 2023 Feb; 51(2):3000605221139704. PubMed ID: 36802838
    [Abstract] [Full Text] [Related]

  • 22. Prediction of Coronary Artery Lesions in Patients With Recurrent Kawasaki Disease.
    Yang P, Zhang J, Liu Y, Feng S, Yi Q.
    Pediatr Infect Dis J; 2024 Feb 01; 43(2):101-108. PubMed ID: 37922481
    [Abstract] [Full Text] [Related]

  • 23. The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.
    An HS, Kim GB, Song MK, Lee SY, Kwon HW, Lee JW, Bae EJ.
    Pediatr Rheumatol Online J; 2021 Jun 02; 19(1):78. PubMed ID: 34078404
    [Abstract] [Full Text] [Related]

  • 24. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct 02; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

  • 25. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 26. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX, Gong FQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 21; 10(5):617-9. PubMed ID: 18947484
    [Abstract] [Full Text] [Related]

  • 27. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
    Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A.
    Circulation; 2006 Jun 06; 113(22):2606-12. PubMed ID: 16735679
    [Abstract] [Full Text] [Related]

  • 28. Outcomes of Kawasaki Disease: A Single-Center Experience.
    Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E.
    Clin Pediatr (Phila); 2015 Jun 06; 54(6):579-84. PubMed ID: 25475592
    [Abstract] [Full Text] [Related]

  • 29. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
    Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, Liu F.
    J Epidemiol; 2020 Oct 05; 30(10):429-435. PubMed ID: 31548437
    [Abstract] [Full Text] [Related]

  • 30. [Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases].
    Wen YN, Chen J, Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun 15; 25(6):572-578. PubMed ID: 37382125
    [Abstract] [Full Text] [Related]

  • 31. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Jun 15; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 32. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study.
    Türkuçar S, Kaya ÜA, Çakmak F, Haşlak F, Demir F, Karabulut E, Makay B, Bilginer Y, Ayaz NA, Sözeri B, Kasapçopur Ö, Karagöz T, Ünal N, Özen S, Ünsal E.
    Turk J Pediatr; 2023 Jun 15; 65(1):64-72. PubMed ID: 36866986
    [Abstract] [Full Text] [Related]

  • 33. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
    J Microbiol Immunol Infect; 2007 Oct 15; 40(5):395-400. PubMed ID: 17932598
    [Abstract] [Full Text] [Related]

  • 34. Kawasaki Disease and Clinical Outcome Disparities Among Black Children.
    Padilla LA, Collins JL, Idigo AJ, Lau Y, Portman MA, Shrestha S.
    J Pediatr; 2021 Feb 15; 229():54-60.e2. PubMed ID: 32980379
    [Abstract] [Full Text] [Related]

  • 35. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
    Pediatr Cardiol; 2021 Apr 15; 42(4):969-977. PubMed ID: 33682062
    [Abstract] [Full Text] [Related]

  • 36. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct 15; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 37. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L, Zhang J, Zhong J, Zheng Y.
    J Interferon Cytokine Res; 2020 Mar 15; 40(3):159-167. PubMed ID: 31841639
    [Abstract] [Full Text] [Related]

  • 38. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E, Małecka-Tendera E, Gawlik T, Firek-Pędras M, Szydłowski L, Gawlik A.
    Kardiol Pol; 2017 Mar 15; 75(3):261-266. PubMed ID: 27995598
    [Abstract] [Full Text] [Related]

  • 39. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Mar 15; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 40. Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease.
    Koné-Paut I, Tellier S, Belot A, Brochard K, Guitton C, Marie I, Meinzer U, Cherqaoui B, Galeotti C, Boukhedouni N, Agostini H, Arditi M, Lambert V, Piedvache C.
    Arthritis Rheumatol; 2021 Jan 15; 73(1):151-161. PubMed ID: 32779863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.